ATM and neoplasm: Our analysis is limited by the potential limitations of tumor-only DNA sequencing, the sample size and the paucity of pathogenic alterations in some genes (for example, ATM), although other studies have also been unable to confirm the relationship between these molecular alterations and clinical outcomes in patients with MIBC36,39.